Cetera Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-1,000
Closed -$1K – 784
2017
Q3
$1K Buy
+1,000
New +$1K ﹤0.01% 830
2016
Q4
– Sell
-1,000
Closed -$1K – 735
2016
Q3
$1K Buy
+1,000
New +$1K ﹤0.01% 770

Other funds holding BMY

Cetera Advisors's BMY Position: Q1 2024 in Review

Cetera Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 121,611 shares — an estimated $6.24M sold.

Cetera Advisors first reported a position in BMY in Q2 2013 and held it in 43 quarters. The position peaked at $12.1M in Q2 2022. 2,334 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Cetera Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • Cetera Advisors sold 121,611 Bristol-Myers Squibb shares in Q1 2024, an estimated $6.24M.
  • Cetera Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 43 quarters.
  • Cetera Advisors's Bristol-Myers Squibb position peaked at $12.1M in Q2 2022.
  • 2,334 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024.